Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Sep 20, 2024)

Date Submitted: Nov 3, 2023
Open Peer Review Period: Nov 3, 2023 - Dec 29, 2023
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Assessing the Accuracy of an Electronic Platform for Childhood Illnesses Management in Rual China: A Cluster Randomized Controlled Trial

  • Puhong Health; 
  • Yang Zhao Yang Zhao; 
  • Jie Jie Shang; 
  • Duolikun Nadila; 
  • Tao Li; 
  • Yu Liu; 
  • Gulizat Abdurixit; 
  • Jane Elizabeth Hirst

ABSTRACT

Background:

The Integrated Management of Childhood Illness (IMCI) faces challenges like high training costs and limited literacy among community health workers (CHWs), resulting in low adherence. Electronic IMCI (eIMCI) platforms with training modules may address these limitations but require further evaluation.

Objective:

This study aims to evaluate an eIMCI platform for training support and disease management in rural China.

Methods:

A cluster randomized controlled trial was conducted in western China. 24 CHWs and 72 children aged 2-5 years treated by them (3 per CHW) were randomized into intervention and control groups. The intervention group received online training and used the eIMCI platform for disease management. The control group received traditional in-person training and paper-based IMCI. The primary outcome was the proportion of children correctly diagnosed/classified by the CHWs as deemed by a pediatric specialist. Poisson regression with Generalized Linear Models estimated the relative risk (RR) between groups, adjusting for CHW clustering, CHW variables (age, sex, education), and patient variables (age, sex, disease number).

Results:

13 CHWs treated 39 children in the intervention group, and 11 CHWs treated 33 children in the control group. Correct classification was significantly higher in the intervention versus control group (64.1% vs 39.4%, P=.036). Multivariable regression confirmed this improvement (RR=2.10, 95% CI: 1.45-3.06; P<.001). Correct treatment increased non-significantly (38.5% vs 27.3%, P=.316). Online training reduced time and costs by ~80% but with a minor decline in post-training scores.

Conclusions:

With substantially lower training burden, the eIMCI platform demonstrated potential to improve IMCI in rural China. Clinical Trial: Chinese Clinical Trial Registry: ChiCTR2100042533 (https://www.chictr.org.cn/showproj.html?proj=119995)


 Citation

Please cite as:

Health P, Yang Zhao YZ, Jie Shang J, Nadila D, Li T, Liu Y, Abdurixit G, Hirst JE

Assessing the Accuracy of an Electronic Platform for Childhood Illnesses Management in Rual China: A Cluster Randomized Controlled Trial

JMIR Preprints. 03/11/2023:54264

DOI: 10.2196/preprints.54264

URL: https://preprints.jmir.org/preprint/54264

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.